AKT1 and diabetes mellitus: In cardiomyocytes, UII also increases phosphorylation of Akt and its downstream target GSK-3β, a serine/threonine protein kinase discovered for its property to inhibit glycogen synthase that has been implicated in many disease states, among others tumorigenesis, diabetes or neurodegenerative diseases [31].